Cargando…
Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios
INTRODUCTION: There is a need for sensitive and specific biomarkers to predict kidney damage and therapeutic response in lupus nephritis (LN). Monocyte chemoattractant protein-1 (MCP-1) and epidermal growth factor (EGF) are cytokines with divergent roles. EGF or EGF/MCP1 ratio have been shown to cor...
Autores principales: | Ngamjanyaporn, Pintip, Worawichawong, Suchin, Pisitkun, Prapaporn, Khiewngam, Khantong, Kantachuvesiri, Surasak, Nongnuch, Arkom, Assanatham, Montira, Sathirapongsasuti, Nuankanya, Kitiyakara, Chagriya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912200/ https://www.ncbi.nlm.nih.gov/pubmed/35271583 http://dx.doi.org/10.1371/journal.pone.0263778 |
Ejemplares similares
-
Years of life lost and long-term outcomes due to glomerular disease in a Southeast Asian Cohort
por: Janphram, Chitimaporn, et al.
Publicado: (2023) -
Pilot study to investigate differences in middle molecules, oxidative stress and markers of peripheral vascular disease in patients treated by high flux haemodialysis and haemodiafiltration
por: Nongnuch, Arkom, et al.
Publicado: (2021) -
Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)
por: Kananuraks, Sarassawan, et al.
Publicado: (2020) -
Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker
por: Anekthanakul, Krittima, et al.
Publicado: (2021) -
Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)